TLR7 ligand-cyclodextrin conjugate is a promising adjuvant for intranasal influenza vaccine.

Jufuku R, Shinchi H, Murata K, Chan M, Hayashi T, Cottam HB, Carson DA, Suda Y, Wakao M

Open source

DOI
10.1016/j.vaccine.2026.128762
Published
2026 Jun 20
Container
Vaccine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.vaccine.2026.128762,
  title = {TLR7 ligand-cyclodextrin conjugate is a promising adjuvant for intranasal influenza vaccine.},
  author = {Jufuku R and Shinchi H and Murata K and Chan M and Hayashi T and Cottam HB and Carson DA and Suda Y and Wakao M},
  year = {2026},
  journal = {Vaccine},
  doi = {10.1016/j.vaccine.2026.128762},
  url = {https://doi.org/10.1016/j.vaccine.2026.128762}
}

RIS

TY  - JOUR
TI  - TLR7 ligand-cyclodextrin conjugate is a promising adjuvant for intranasal influenza vaccine.
AU  - Jufuku R
AU  - Shinchi H
AU  - Murata K
AU  - Chan M
AU  - Hayashi T
AU  - Cottam HB
AU  - Carson DA
AU  - Suda Y
AU  - Wakao M
PY  - 2026
JO  - Vaccine
DO  - 10.1016/j.vaccine.2026.128762
UR  - https://doi.org/10.1016/j.vaccine.2026.128762
ER  - 

APA

R, J., H, S., K, M., M, C., T, H., HB, C., DA, C., Y, S., & M, W. (2026). TLR7 ligand-cyclodextrin conjugate is a promising adjuvant for intranasal influenza vaccine.. Vaccine. https://doi.org/10.1016/j.vaccine.2026.128762

Source records